OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 77 filers reported holding SYNTHETIC BIOLOGICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q2 2017$424,000,000
-32.8%
749,848
-25.0%
0.01%
-36.4%
Q1 2017$631,000,000
-17.3%
1,000,0000.0%0.01%
-26.7%
Q4 2016$763,000,0001,000,0000.02%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Third Security, LLC 13,238,268$6,726,0000.58%
MSD Partners, L.P. 4,118,402$2,092,0000.11%
683 Capital Management, LLC 1,500,000$762,0000.06%
Vivaldi Capital Management LP 101,145$51,0000.04%
Alyeska Investment Group, L.P. 5,000,000$2,540,0000.02%
BARD ASSOCIATES INC 56,499$29,0000.01%
FRANKLIN STREET ADVISORS INC /NC 126,000$64,0000.01%
Virtu Financial LLC 299,577$152,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 46,981$24,0000.01%
Stanley-Laman Group, Ltd. 60,323$31,0000.01%
View complete list of SYNTHETIC BIOLOGICS INC shareholders